Latest Private investor biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

InKemia presenta un Foro para dinamizar las inversiones en jóvenes empresas de ciencias de la vida

by InKemia IUCT group

El “Fondo de Capital Conocimiento” de InKemia tiene como misión principal la detección de empresas jóvenes de los Sectores Biotecnológico, Químico, Farmacéutico y afines (cosmecéutico, comp...

Mind the Byte gets international in Denmark

by Mind the Byte

9 years ago
Mind the Byte, InKemia IUCT Group, crowdfunding

Mind the Byte –located at Barcelona Science Park (PCB) and specializing in the development of cloud technologies for drug discovery– just opened a branch at the Copenhagen Bio Science Park (COBIS)...

Montserrat Vendrell: 'Now investors see our sector as a business opportunity'

by Biocat

9 years ago
Biocat, Barcelona Institute of Science and Technology, Montserrat Vendrell, BioRegió

I would like for the success stories not to be counted on one hand, for investors worldwide to know Barcelona and Catalonia as a place they’re interested in doing business and for our companies to b...

Bayer trae a Barcelona la iniciativa Grants4Apps de ayuda a las 'start-up' innovadoras en salud digital

by Biocat

9 years ago
Grant4Apps, Bayer, eHealth, mHealth, startups

Los cinco proyectos seleccionados podrán trabajar en las oficinas de Sant Joan Despí durante seis meses y recibirán 'mentoring' y 'coaching' de expertos del grupo

Health & Bio Team Dating', a new initiative to bring together entrepreneurs and scientists

by Parc Científic de Barcelona

9 years ago
Health & Bio Team Dating, Barcelona Science Park (PCB), Biocat, CataloniaBio, Bosch i Gimpera Foundation (FBG), Banc Sabadell

Scientists and entrepreneurs will meet in short partnering meetings to combine their experience and projects with the aim of building a balanced team to lead successful start-up in the life sciences.

ProA Capital adquiere la mayoría del capital de Suanfarma

by Professional Newco

9 years ago
ProA Capital, Suanfarma

La entrada de ProA Capital, realizada a través de una ampliación de capital, busca potenciar el crecimiento de Suanfarma, tanto de manera orgánica como mediante adquisiciones. El equipo directivo d...

Minoryx Therapeutics completes Series A funding of €19.4M ($21.7M)

by Ysios Capital

9 years ago
orphan diseases, Minoryx Therapeutics, Caixa Capital Risc, Ysios Capital, Ysios BioFund II Innvierte, SEE-Tx, X-ALD, MIN-102, Roche Venture Fund, Kurma Partners, Idinvest Partners, Chiesi Ventures, HealthEquity

Ysios Capital, a Spanish investment fund, led the round. The fundraising was also supported by a substantial syndicate of new investors including Kurma Partners, Roche Venture Fund, Idinvest Partners ...

InKemia: entra en Pharmamel, acude a la ampliación de capital de Mind the Byte y firma un acuerdo con Barcelona Bioscience

by InKemia IUCT group

9 years ago
InKemia IUCT Group, InKemia, Barcelona Bioscience, Mind the Byte, Pharmamel

InKemia IUCT Group ha informado este 14 de octubre mediante nota remitida al MAB de tres hechos que fortalecen la estrategia del grupo de creación de una red sinérgica de empresas participadas y col...

Neol Bio completa la ampliación de capital previa a su salida al MAB

by Neuron Bio

9 years ago
Neol Bio, ampliación de capital, MAB

La ampliación, dirigida a inversores cualificados, se ha completado al 100%. Neol Bio empezará a cotizar en el Mercado Alternativo Bursátil (MAB) próximamente, una vez cumplimentados los requisito...

Timac Agro and the University of Navarra create a cathedra in order to produce sustainable models of environmental development

by Universidad de Navarra

1.5 million euro for foreseeing the effects of climate change on plant nutrition and development. The length of this agreement is of five years, automatically extendable, and it includes the financing...

Artax Biopharma Raises $10M Series B to fund Phase Ib-IIa clinical trials for AX-024, a novel oral treatment for autoimmune diseases and to further develop its pipeline of preclinical candidates

by Parc Científic de Barcelona

9 years ago
Advent Life Sciences, Artax Biopharma, AX-024 compound

Artax has validated the target and mechanism of action, and demonstrated preclinical proof of concept of AX-024 in various preclinical autoimmune disease (MS, Psoriasis, IBD, Type I diabetes) and GVHD...

Precipita platform raises funds for research in Cornelia de Lange syndrome at IDIBELL

by IBEC - Institut de Bioenginyeria de Catalunya

9 years ago
Cornelia de Lange Syndrome (CDLS), crowdfunding platform, rare disease, Precipita

The campaign started at Precipita crowdfunding platform aims to raise 25,000 euros for sequencing the genome of several patients looking for several markers that may be useful both for understanding t...